🇺🇸 FDA
Pipeline program

Bone marrow mononuclear cells

CMMo/CIC/2009

Phase 2 other completed

Quick answer

Bone marrow mononuclear cells for Chronic Myocardial Ischemia is a Phase 2 program (other) at Lxo Ireland Designated Activity Company with 1 ClinicalTrials.gov record(s).

Program details

Company
Lxo Ireland Designated Activity Company
Indication
Chronic Myocardial Ischemia
Phase
Phase 2
Modality
other
Status
completed

Clinical trials